Metabolic & Weight Management

PYY

Peptide YY (PYY 3-36)

A gut hormone released after meals that reduces appetite by acting on hypothalamic NPY receptors. PYY 3-36 is the active form that crosses the blood-brain barrier.

SatietyAppetiteGut-BrainWeight LossNeuropeptide Y

Quick Reference

Category
Metabolic & Weight Management
Research Claims
3 reviewed
Explore Research

Mechanism of Action

PYY 3-36 binds to Y2 receptors in the hypothalamus, inhibiting NPY/AgRP neurons and reducing appetite. It also slows gastric emptying and reduces GI motility.

Health Claims & Evidence

Reduces appetite and food intake

Strongintranasal PYY 3-36 reduces caloric intake in human studies

Promotes satiety after meals

Strongphysiological role in meal termination well-established

Potential obesity treatment

Moderateclinical trials show appetite reduction and weight loss

Short-Term Effects

Reduced appetite and food intake within 30–60 minutes.

Long-Term Effects

Potential for sustained appetite reduction with regular use.

Side Effects

Nausea (dose-dependent), headache.

Contraindications

Use with caution in eating disorders.

This profile is provided for educational research only. It is not a treatment recommendation or dosing guide. Human evidence, safety information and regulatory status vary by substance. Verify primary sources and consult a qualified healthcare professional for medical decisions.

Research Papers

PYY 3-36 reduces food intake in humans

Batterham et al. · Nature · 2002

Educational research only. This profile is not a treatment recommendation or dosing guide. Human evidence, safety information and regulatory status vary by substance. Consult a qualified healthcare professional for medical decisions.

Related Peptides

Explore the research further

Our AI Research Advisor can help you explore the evidence on PYY and related peptides, and prepare an educational research summary.

Explore Research